Loading clinical trials...
Loading clinical trials...
A Randomized, Single-dose, Partial Replicate, Three-phase, Three-sequence, Open-label, Bioequivalence Study Comparing Quetiapine 25 mg in Different Products After Oral Administration to Healthy Adult Subjects Under Fasting Conditions
Conditions
Interventions
Test product (T) 25 mg Film Coated Tablets
Reference product (R) 25 mg Film Coated Tablets
Locations
1
Egypt
Future Research Center (FRC)
Cairo, Egypt
Start Date
May 19, 2021
Primary Completion Date
June 3, 2021
Completion Date
June 3, 2021
Last Updated
February 11, 2022
NCT07345130
NCT06969963
NCT06924190
NCT06830954
NCT06758531
NCT06600282
Lead Sponsor
Future University in Egypt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions